The facts on small-cell lung cancer, or SCLC, and non-small-cell lung cancer, or NSCLC, like symptoms, prognosis, treatment, and recovery.

Small cell lung cancer is aggressive and spreads quickly. There are many options for treatment, depending on the type and stage of SCLC.

When non-small cell lung cancer (NSCLC) spreads beyond the lungs, it often metastasizes to the bones. Estimates suggest 20 to 30 percent of people with NSCLC have bone metastases at the time of ...

Non-small-cell lung cancer (NSCLC) is the most common form of lung cancer. Early NSCLC is when your disease is in its earliest stages, or stages I-II. That means that your lung tumor has grown and ...

The drug was approved to treat patients who have already received chemotherapy under an accelerated approval process after a ...

During a live event, Neal E. Ready, MD, and participants discussed what factors justify using PD-1 plus CTLA-4 inhibitor and ...

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, accounting for 80-85% of all cases. It develops when abnormal lung cells grow uncontrollably, forming a tumor.

A new research paper was published in Volume 16 of Oncotarget on June 17, 2025, titled "Molecular landscape of HER2-mutated ...

Access free, up-to-date clinical references on the presentation, diagnosis and assessment of non-small cell lung cancer at Healio. Clinical Guidance content provides valuable insights for physicians.

This year in review of 2024 milestones in non–small cell lung cancer (NSCLC) features coverage of the LAURA trial presented in June at the American Society of Clinical Oncology meeting in ...